Feed Preview

Fast Growing

Avian Influenza: Innate Immune Adjuvant

Avian Influenza: Innate Immune Adjuvant diagram by undefined

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Top 20 most recent papers

Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

ScienceDecember 6, 2019
Kevin O. SaundersBarton F. Haynes

Comparison of intradermal injection and epicutaneous laser microporation for anti-tumor vaccine delivery in a human skin explant model

bioRxivDecember 5, 2019
Sanne DuinkerkenYvette van Kooyk

State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

AllergyNovember 27, 2019
Erika Jensen-JarolimThomas M Kundig
ACS Applied Materials & Interfaces

Polyethyleneimine Hybrid Thin Shell Hollow Mesoporous Silica Nanoparticles as Vaccine Self-Adjuvants for Cancer Immunotherapy

ACS Applied Materials & InterfacesNovember 27, 2019
Qianqian LiuJuan Tao
Infection and Immunity

Vaccine-specific immune responses against Mycobacterium ulcerans infection in a low-dose murine challenge model

Infection and ImmunityDecember 9, 2019
Kirstie M. MangasTimothy Paul Stinear

Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix

VaccinesDecember 6, 2019
Wesley de JongRob A Gruters
PLoS Pathogens

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

PLoS PathogensDecember 1, 2019
Celia C. LaBrancheDavid Charles Montefiori

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins

VaccinesDecember 3, 2019
Bassel AkacheMichael J McCluskie
Cell Reports

Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization

Cell ReportsDecember 3, 2019
K Rachael ParksLeonidas Stamatatos

Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines

VirusesDecember 3, 2019
Chen ChenLing Zhao
Organic & Biomolecular Chemistry

Stereochemistry, lipid length and branching influences Mincle agonist activity of monoacylglycerides

Organic & Biomolecular ChemistryNovember 27, 2019
Ayesha KhanBridget L Stocker
Metabolic Engineering

Metabolic engineering of Escherichia coli to produce a monophosphoryl lipid A adjuvant

Metabolic EngineeringNovember 28, 2019
Yu Hyun JiHak Suk Chung
Clinical Genitourinary Cancer

Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer

Clinical Genitourinary CancerNovember 6, 2019
David D'AndreaDaher Cezar Chade
Medicinal Research Reviews

Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy

Medicinal Research ReviewsDecember 2, 2019
Jun-Jun WuYan-Mei Li
BioMed Research International

VLPs Derived from the CCMV Plant Virus Can Directly Transfect and Deliver Heterologous Genes for Translation into Mammalian Cells

BioMed Research InternationalOctober 29, 2019
María V Villagrana-EscareñoJ Ruiz-García
PLoS Pathogens

ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type

PLoS PathogensDecember 1, 2019
Luca SchifanellaGenoveffa Franchini
Cancer Immunology, Immunotherapy : CII

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models

Cancer Immunology, Immunotherapy : CIIDecember 5, 2019
Rui ZhangLi Yang
Journal of Neuroinflammation

Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats

Journal of NeuroinflammationDecember 3, 2019
Petri EloAnne Roivainen
Influenza and Other Respiratory Viruses

Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement

Influenza and Other Respiratory VirusesNovember 27, 2019
Atin Khalaj-HedayatiKhai Wooi Lee
Journal of Inorganic Biochemistry

Cognition and behavior in sheep repetitively inoculated with aluminum adjuvant-containing vaccines or aluminum adjuvant only

Journal of Inorganic BiochemistryNovember 20, 2019
Javier AsínLluís Luján

See more papers from this feed

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.


Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Bacillus Cereus Infection

Bacillus Cereus is a gram-positive bacteria that is the cause of some foodborne illnesses and leads to diarrhea and vomiting. Discover the latest research on Bacillus Cereus Infection here.

© 2019 Meta ULC. All rights reserved